Activest Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$466 Buy
34
+20
+143% +$273 ﹤0.01% 907
2026
Q2
$190 Sell
14
-170
-92% -$2.03K ﹤0.01% 1176
2026
Q1
$1.1K Sell
184
-154
-46% -$1.16K ﹤0.01% 1019
2025
Q4
$2.42K Buy
338
+334
+8,350% +$2.64K ﹤0.01% 863
2025
Q3
$43 Sell
4
-69
-95% -$677 ﹤0.01% 1089
2025
Q2
$707 Buy
73
+50
+217% +$516 ﹤0.01% 815
2025
Q1
$342 Buy
+23
New +$354 ﹤0.01% 890
2023
Q1
– Sell
-16
Closed -$552 – 465
2022
Q4
$552 Hold
16
– – ﹤0.01% 432
2022
Q3
$1K Buy
+16
New +$483 ﹤0.01% 416

Other funds holding OGN

Activest Wealth Management's OGN Position: Q3 2026 in Review

Activest Wealth Management increased its Organon & Co (OGN) stake by 143% in Q3 2026, buying an estimated $273 and bringing the position to 34 shares worth $466. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Activest Wealth Management first reported a position in OGN in Q3 2022 and has held it in 9 quarters since. The position peaked at $2.42K in Q4 2025. 608 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Activest Wealth Management held 34 shares of Organon & Co worth $466 as of Q3 2026.
  • Activest Wealth Management bought 20 Organon & Co shares in Q3 2026, an estimated $273.
  • Organon & Co made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #907 holding.
  • Activest Wealth Management first reported a position in Organon & Co in Q3 2022 and has held it in 9 quarters since.
  • Activest Wealth Management's Organon & Co position peaked at $2.42K in Q4 2025.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.